Bendamustine in Monotherapy and in Combination Regimens in the Treatment of Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma - a Retrospective Analysis

被引：0

作者：

Hus, Iwona ^{[1
]}

Jawniak, Dariusz ^{[1
]}

Gorska-Kosicka, Magdalena ^{[1
]}

Butrym, Aleksandra ^{[2
]}

Dzietczenia, Justyna ^{[2
]}

Wrobel, Tomasz ^{[2
]}

Mazur, Grzegorz ^{[2
]}

Lech-Maranda, Ewa ^{[3
]}

Warzocha, Krzysztof ^{[4
]}

Waszczuk-Gajda, Anna ^{[5
]}

Wiktor-Jedrzejczak, Wieslaw ^{[5
]}

Krawczyk-Kulis, Malgorzata ^{[6
]}

Kyrcz-Krzemien, Slawomira ^{[6
]}

Poplawska, Lidia ^{[7
]}

Walewski, Jan ^{[7
]}

Dmoszynska, Anna ^{[1
]}

机构：

[1] Med Univ Lublin, Dept Hematooncol & Bone Marrow Transplantat, Lublin, Poland

[2] Wroclaw Med Univ, Dept Hematol Blood Neoplasms & Bone Marrow Transp, Wroclaw, Poland

[3] Inst Haematol & Transfus Med, Dept Hematol, Warsaw, Poland

[4] Hematol Inst Hematol & Transuzjol, Dept Hematol, Warsaw, Poland

[5] Med Univ Warsaw, Dept Hematol Oncol & Internal Dis, Warsaw, Poland

[6] Silesian Med Univ Katowice, Dept Hematol & Bone Marrow Transplantat, Katowice, Poland

[7] Maria Sklodowska Curie Mem Inst & Canc Ctr, Dept Lymphoid Malignancies, Warsaw, Poland

来源：

BLOOD | 2012年 / 120卷 / 21期

关键词：

D O I：

10.1182/blood.V120.21.4602.4602

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

4602

引用

页数：2

共 50 条

[21] Bendamustine for non-Hodgkin lymphoma
Gribben, John
EXPERT REVIEW OF HEMATOLOGY, 2013, 6 (02) : 123 - 125
[22] Occupation and risk of non-Hodgkin's lymphoma and chronic lymphocytic leukemia
Zheng, TZ
Blair, A
Zhang, YW
Weisenburger, DD
Zahm, SH
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2002, 44 (05) : 469 - 474
[23] Safety and Efficacy of the Combination of Ibrutinib and Nivolumab in Patients with Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia
Younes, Anas
Brody, Joshua
Carpio, Cecilia
Lopez-Guillermo, Armando
Ben-Yehuda, Dina
Ferhanoglu, A. Burhan
Nagler, Arnon
Ozcan, Muhit
Avivi, Irit
Albareda, Francesc Bosch
Barrigon, Maria Dolores Caballero
Masood, Aisha
Streit, Michael
Alvarez, John
Ceulemans, Rob
Masouleh, Behzad Kharabi
Balasubramanian, Sriram
Schaffer, Michael
Wang, Shean-Sheng
Fourneau, Nele
Jurczak, Wojciech
BLOOD, 2017, 130
[24] Fludarabine, cyclophosphamide, and rituximab for the treatment of patients with chronic lymphocytic leukemia or indolent non-Hodgkin lymphoma
Tam, Constantine S.
Wolf, Max
Prince, H. Miles
Januszewicz, E. Henry
Westerman, David
Lin, Katherine I.
Carney, Dennis
Seymour, John F.
CANCER, 2006, 106 (11) : 2412 - 2420
[25] Subcutaneous rituximab with recombinant human hyaluronidase in the treatment of non-Hodgkin lymphoma and chronic lymphocytic leukemia
Hill, Samuel Luke
Davies, Andrew
FUTURE ONCOLOGY, 2018, 14 (17) : 1691 - 1699
[26] The discovery and the development of bendamustine for the treatment of non-Hodgkin lymphoma
Munakata, Wataru
Tobinai, Kensei
EXPERT OPINION ON DRUG DISCOVERY, 2016, 11 (11) : 1123 - 1130
[27] New hope for bendamustine in the treatment of non-Hodgkin lymphoma
Wraight, Sophie
EXPERT REVIEW OF HEMATOLOGY, 2013, 6 (02) : 119 - 119
[28] BENDAMUSTINE: AN OLD DRUG IN THE NEW ERA FOR PATIENTS WITH NON-HODGKIN LYMPHOMAS AND CHRONIC LYMPHOCYTIC LEUKEMIA
Patekar, Martina Bogeljic
Milunovic, Vibor
Jakobac, Karla Misura
Perica, Drazen
Rogulj, Inga Mandac
Kursar, Marin
Planinc-Peraica, Ana
Kolonic, Slobodanka Ostojic
ACTA CLINICA CROATICA, 2018, 57 (03) : 542 - 553
[29] Zanubrutinib: A Novel BTK Inhibitor in Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma
Tam, Constantine S.
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (01) : 32 - 34
[30] Hormone replacement therapy and risk of non-Hodgkin lymphoma and chronic lymphocytic leukemia
Cerhan, JR
Vachon, CM
Habermann, TM
Ansell, SM
Witzig, TE
Kurtin, PJ
Janney, CA
Zheng, W
Potter, JD
Sellers, TA
Folsom, AR
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2002, 11 (11) : 1466 - 1471

← 1 2 3 4 5 →